Orgalan IV injection 1250 units, manufactured by Neocriticare Pharmaceutical, contains Danaparoid sodium, an anticoagulant used to prevent and treat thromboembolic disorders, particularly in patients with heparin-induced thrombocytopenia (HIT). This injectable drug has a YJ code of 3339600A1030 and a standard of 1,250 anti-factor Xa activity units per 1 mL tube.
Orgalan IV injection 1250 units
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).